|
Home
>
Newsletters
>
International Pharmaceutical Regulatory Monitor
> Indian Supreme Court to Hear Final Arguments in Novartis Patent Case
International Pharmaceutical Regulatory Monitor
September 2012
| Vol.
40 No.
9
Indian Supreme Court to Hear Final Arguments in Novartis Patent Case
India’s Supreme Court is set to hear final arguments Sept. 11 in a case between Novartis and the Indian patent office that could have repercussions for the country’s controversial intellectual property (IP) laws and vast generic drug industry.
|
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.